Regulatory status: IVD, FDA Class I
60-0118-7 7mL RTU
61-0118 1mL concentrate
This antibody is an important marker that may demonstrate the myeloid or monocytic nature of acute leukemia. It may aid in the identification of histiocytic neoplasias and classifying lymphoproliferative disorders when used in a panel of antibodies.